Home › Funds › Invesco Ltd › NMRA
Invesco Ltd position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)243.19K sh
Reported value held$413.43K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 13.45K | $132.16K | New |
| Q3 2024 | 13.91K | $183.71K | Add |
| Q4 2024 | 49.25K | $522.04K | Add |
| Q1 2025 | 123.66K | $123.66K | Add |
| Q2 2025 | 132.04K | $96.82K | Add |
| Q3 2025 | 183.80K | $334.51K | Add |
| Q4 2025 | 227.59K | $407.39K | Add |
| Q1 2026 | 205.93K | $401.56K | Reduce |
| Q2 2026 | 243.19K | $413.43K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Citadel Advisors 1.07M sh · $1.82M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Morgan Stanley 319.42K sh · $543.02K · Q2 2026